Park Medi World Intrinsic Value
Park Medi World intrinsic value. Park Medi World (PARKHOSPS) median intrinsic value is ₹197.97 from 9 valuation models (range ₹80–₹520), vs current price ₹267.75 — -26.1% downside (Trading Above Calculated Value), margin of safety -35.2%. Compare with Park Medi World value estimation to assess whether the stock is under or overvalued.
PARKHOSPS Valuation Methods Summary — DCF, Graham Number & P/E
Park Medi World intrinsic value across 9 models vs current price ₹267.75 — upside/downside and value range per method. For current market price and key ratios, visit Park Medi World share price today.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹85.44 | ₹68.35 - ₹102.53 | -68.1% | EPS: ₹7.12, Sector P/E: 12x |
| Book Value Method | asset | ₹244.65 | ₹220.19 - ₹269.12 | -8.6% | Book Value/Share: ₹244.65, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹174.14 | ₹156.73 - ₹191.55 | -35.0% | Revenue/Share: ₹217.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹376.74 | ₹339.07 - ₹414.41 | +40.7% | EBITDA: ₹540.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹519.64 | ₹415.71 - ₹623.57 | +94.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹80.33 | ₹72.30 - ₹88.36 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹80.33 | ₹72.30 - ₹88.36 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹429.77 | ₹386.79 - ₹472.75 | +60.5% | ROE: 14.6%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹197.97 | ₹178.17 - ₹217.77 | -26.1% | EPS: ₹7.12, BVPS: ₹244.65 |
PARKHOSPS Intrinsic Value vs Market Price — All Valuation Models
Park Medi World fair value range ₹80–₹520 vs current market price ₹267.75 across 9 valuation models. Read PARKHOSPS dividend yield for the complete payout history and dividend yield track record.
PARKHOSPS Intrinsic Value Analysis — Undervalued or Overvalued?
Park Medi World median intrinsic value ₹197.97, current price ₹267.75 — Trading Above Calculated Value by 26.1%, margin of safety -35.2%.
What is the intrinsic value of PARKHOSPS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Park Medi World (PARKHOSPS) is ₹197.97 (median value). With the current market price of ₹267.75, this represents a -26.1% variance from our estimated fair value.
The valuation range spans from ₹80.33 to ₹519.64, indicating ₹80.33 - ₹519.64.
Is PARKHOSPS undervalued or overvalued?
Based on our multi-method analysis, Park Medi World (PARKHOSPS) appears to be trading above calculated value by approximately 26.1%.
PARKHOSPS Financial Health — Key Ratios vs Industry Benchmarks
Park Medi World financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 6.04 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 14.6% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 28.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.67x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
PARKHOSPS Cash Flow Quality — Operating & Free Cash Flow
Park Medi World operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹329 Cr | ₹171 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹215 Cr | ₹165 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹367 Cr | ₹329 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹199 Cr | ₹82 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹155 Cr | ₹31 Cr | Positive Free Cash Flow | 7/10 |